Two Sigma Securities’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
Other funds holding MTNB
DS
HIW
XT
Two Sigma Securities's MTNB Position: Q4 2025 in Review
Two Sigma Securities sold out of Matinas BioPharma (MTNB) in Q4 2025, closing a stake of 12,560 shares — an estimated $23.7K sold.
Two Sigma Securities first reported a position in MTNB in Q2 2017 and held it in 10 quarters. The position peaked at $94K in Q3 2021. 30 funds tracked by Wall St. Rank hold MTNB as of Q4 2025.
- Two Sigma Securities reported no remaining Matinas BioPharma position as of Q4 2025 after selling out during the quarter.
- Two Sigma Securities sold 12,560 Matinas BioPharma shares in Q4 2025, an estimated $23.7K.
- Two Sigma Securities first reported a position in Matinas BioPharma in Q2 2017 and held it in 10 quarters.
- Two Sigma Securities's Matinas BioPharma position peaked at $94K in Q3 2021.
- 30 funds tracked by Wall St. Rank held Matinas BioPharma as of Q4 2025.
Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.